Hypolipidemic Drugs and Diabetes Mellitus—Mechanisms and Data From Genetic Trials
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cardiovascular Pharmacology and Therapeutics"
DOI: 10.1177/1074248418757011
Abstract: Clinical trials and meta-analyses have shown that statins can dose dependently increase the incidence of new-onset diabetes mellitus (DM) especially in patients with underlying abnormalities of carbohydrate homeostasis. Mendelian randomization studies support these findings since… read more here.
Keywords: ldl receptor; receptor expression; target; diabetes mellitus ... See more keywords
HPTLC-Bioluminescent Bioautography Screening of Herbal Teas for Adulteration with Hypolipidemic Drugs
Sign Up to like & getrecommendations! Published in 2023 at "Biosensors"
DOI: 10.3390/bios13030392
Abstract: Teas based on nutraceutical herbs are an effective tool against hyperlipidemia. However, the adulteration with chemical drugs is frequently detected. By coupling bioluminescent bioautography with high performance thin-layer chromatography (HPTLC), we developed a facile method… read more here.
Keywords: bioluminescent bioautography; herbal teas; hypolipidemic drugs; adulteration ... See more keywords